The Magdalen Centre Oxford Science Park Robert Robinson Avenue Oxford OX4 4GA
+44 1865 784777
OxSonics® aims to provide a drug-class-agnostic solution to the greatest challenge in oncological drug delivery: the inability of therapeutic agents to effectively penetrate solid tumours.
The SonoTran® drug delivery platform is designed for the oncology ward and can be used seamlessly with a broad range of current and future therapeutic agents aimed at treating solid tumours. The technique is equally applicable to already marketed and investigational therapeutic agents through partnerships with oncology drug developers. SonoTran utilizes a purely mechanical effect, triggered by ultrasound applied non-invasively, to actively transport therapeutics throughout tumours without the need for drug reformulation. The same device not only enhances but also enables mapping of the drug delivery process, confirming that the treatment is being successfully applied to the target tissues in real time.